Cointime reports: Innovative drug concept stocks on China’s A-share market rallied in volatile trading, with Wanbang Biopharma gaining more than 10%. Warner Pharmaceutical, Xuanzhu Pharma, Chengdu HitGen, Zhongsheng Pharmaceutical and Nearshore Protein led the gains. The move reflects renewed investor interest in the sector, though no specific catalyst was disclosed in the market data.
China A-share innovative drug stocks rally; Wanbang Biopharma up over 10%
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
46m ago
Strategy’s STRC Perpetual Preferred Slips ~4% Below Peg to $96.35
56m ago
StoneX cuts Bitdeer price target to $15, keeps Buy rating
1h ago
Dow Falls 1% as US Stocks Extend Losses
2h ago
Nasdaq Opens Up 0.7% as AI-Linked Stocks Rally on Nvidia Outlook
2h ago
UBS Cuts Nvidia Price Target to $220 from $240
3h ago
Zcash Spot ETF Filed by Bitwise for Texas Stock Exchange Listing